The Japanese Society of Toxicologic Pathology has accepted a paper for publication in its upcoming journal. Entitled “Utilizing Novel Telepathology System in Preclinical Studies and Peer Review”, the paper describes the use of Augmentiqs real-time telepathology in pre-clinical studies involving non-U.S. sponsors performing studies at CROs in the U.S.

Click here to view the advanced publication at JStage.